News

Clearside Biomedical Announces Financial Results and Updates

Clearside Biomedical Announces Financial Results and Updates

Exciting Updates from Clearside Biomedical

ALPHARETTA, Ga. — Clearside Biomedical, Inc. (Nasdaq: CLSD), a pioneering biopharmaceutical company, is set to report its fourth quarter and full year 2024 financial results on Thursday, March 27, 2025. This announcement promises to shed light on the company’s ongoing journey in revolutionizing eye treatment through innovative delivery methods.

Understanding Clearside's Approach

Clearside Biomedical has carved out a unique niche in the biopharmaceutical industry by focusing on the delivery of therapies directly to the back of the eye via the suprachoroidal space (SCS). This method allows for more effective treatment of various eye disorders, potentially preserving and enhancing vision for patients with sight-threatening conditions. The company's patented SCS Microinjector facilitates a non-surgical, in-office procedure, making treatment both comfortable and efficient.

Innovative Product Pipeline

Clearside's lead program, CLS-AX, which is an injectable suspension of axitinib, is currently being developed to combat neovascular age-related macular degeneration (wet AMD). As part of the development process, exciting plans for a Phase 3 clinical program are underway, which could bring significant advancements in treatment for patients suffering from this condition. The company is also exploring potential long-acting agents for geographic atrophy (GA), further broadening its impact in ocular therapeutics.

Recent Achievements and Future Directions

One of Clearside's standout achievements is the successful launch of its first product, XIPERE, a triamcinolone acetonide injectable suspension that is designed for suprachoroidal use. Currently available in the U.S. through a commercial partner, XIPERE's introduction reflects the efficacy of Clearside's innovative approaches. Moreover, the company is continuously enhancing its pipeline and actively seeking collaborations to expand its SCS injection platform with other ophthalmic therapies.

Access to Upcoming Financial Results

Management will host a conference call on March 27 at 4:30 p.m. Eastern Time to discuss the financial outcomes and to provide a more comprehensive overview of the company's corporate activities and future initiatives. This event will be available through a live webcast, enabling stakeholders and interested parties to join remotely and gain insights into the company’s financial health and strategic direction. Attendees are encouraged to log in 15 minutes before the event to secure their participation.

Staying Connected with Clearside

For those interested in staying updated with Clearside Biomedical, the company maintains a wealth of resources through its official website. Interested individuals can follow Clearside on their social media platforms, including LinkedIn and X, to get the latest news and updates on their products and innovations in ocular drug delivery. Engaging with the company through these platforms is an excellent way to stay informed about ongoing advancements and achievements.

Frequently Asked Questions

1. What is Clearside Biomedical known for?

Clearside Biomedical specializes in the innovative delivery of therapies to the back of the eye using its suprachoroidal space (SCS) method, which improves patient outcomes.

2. When will Clearside report its financial results for 2024?

The company plans to report its fourth quarter and full year financial results on March 27, 2025.

3. What are some of Clearside's key products?

Clearside's key products include CLS-AX, aimed at treating wet AMD, and XIPERE, an injectable suspension for suprachoroidal use.

4. How can I access the financial results webcast?

The live webcast of the financial results will be available on Clearside's website, under the Investors section, allowing broader access for all interested parties.

5. How can I keep up with Clearside Biomedical's news?

You can follow Clearside Biomedical on their website and social media platforms like LinkedIn and X for the latest updates and announcements.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Classys Rides Revenue Surge, Eyes China Growth

Updated Category News Views 93

Strong Numbers, But There's More to Unpack Nine months into 2026, Classys Inc. ain't exactly putting up shabby numbers. They've rolled in with KRW 275.7 billion like it was a stroll in the park, marking a sturdy 13% jump from last year. Yet, with all this, their operating profit has taken a 9.4% spill. It's a mixed bag, folks, and Classys is gearing up for a massive...

Continue Reading
AST SpaceMobile Faces Class Action Suit Deadline Looms

Updated Category News Views 95

AST SpaceMobile's Securities Class Action: The Lowdown When you roll the dice on a company like AST SpaceMobile, Inc. (NASDAQ: ASTS), you want to believe that you're betting on the stars. But lately, some investors might feel like they're seeing more darkness than starlight. Here's the kicker: AST SpaceMobile is staring down a securities fraud class action lawsuit. It's a...

Continue Reading
CSTS Backs Hong Kong's Nobel Sustainability Trust Put

Updated Category News Views 101

A New Chapter for CSTS and Sustainability Leadership Who would've thunk it? CSTS Enterprises, primarily known for its integrated media and sports ventures, is stepping into the sustainability arena as the Official Hospitality Partner for the Nobel Sustainability Trust Hong Kong Summit 2026. They're not just dipping a toe—they're diving headfirst into the pool, bringing...

Continue Reading
Fitness Career Platform's Big Ramp Up Sparks Buzz

Updated Category News Views 73

ISSA Career Connect Gains Industry Recognition In a world where finding that first job post-certification can be as brutal as a spin class in August, ISSA Career Connect seems to be offering a bit of a lifeline. This platform, already making some serious noise in the fitness industry, has just snagged a place as a finalist for App of the Year at the 2026 Beyond Activ...

Continue Reading
Will Hair Loss Drugs Challenge Transplant Clinics?

Updated Category News Views 54

Emerging Treatments Stir Up Hair Loss Scene You ever get the feeling we're on the brink of something big? That's where we are with hair loss treatments, folks. As of late 2026, new drugs are making waves in clinical trials, but they’re not yet giving hair transplant clinics any sleepless nights. Smile Hair Clinic's co-founders, Dr. Mehmet Erdo?an and Dr. Gökay Bilgin,...

Continue Reading
Cangzhou's Bold Bid: Inviting Global Media to Witness Growth

Updated Category News Views 104

From Cultural Riches to Industrial Powerhouse Ever been to Cangzhou? No? Well, the folks there want to change that narrative pronto. This coastal gem in northern China is throwing open its doors to the global media with a big ol’ invitation to see, explore, and spread the word about what makes this city tick. Part of the Seventh World Media Summit held in Beijing, this...

Continue Reading
Class Action Looms Over The Chemours Company

Updated Category News Views 112

Chemours Under Fire: What’s Happening? Here we are, in the thick of a legal storm surrounding The Chemours Company. A class-action lawsuit is underway, and it’s painting the company in a rather unflattering light. Now, if you snagged some of that NYSE:CC action between February 20, 2026, and August 4, 2026, there's a chance you’re caught in the crossfire. Per the...

Continue Reading
Webull Faces Class Action: Investors Eye Plaintiff Role

Updated Category News Views 97

Webull Under Fire: What's Happening? In a development that's got investors biting their nails, Webull (NASDAQ:BULL) finds itself caught up in a class action. The folks at Robbins LLP are waving a red flag, urging those who bought into Webull between the dates of April 26, 2025, and October 6, 2026, to sit up and take notice. A class action complaint claims that the...

Continue Reading
OI Investors Crack Down: Class Action Filing Looms

Updated Category News Views 124

O-I Glass Under Fire: The Glass Containers Giant Stumbles If you’ve been watching the ticker for O-I Glass, Inc. (NYSE:OI), you know it’s been a rocky road lately. We’re knee-deep in another saga of corporate promises meeting harsh reality. The novel here isn’t just the $1 trillion industry O-I Glass plays in, but the speed at which its fortunes seem to be...

Continue Reading
Palatin Prepares for FY27 Results Amid Market Curiosity

Updated Category News Views 34

Mark Your Calendars, Investors! Folks grumble about the mundane task of checking fiscal calendars, but without this intel, where are we? On November 17, 2026, Palatin Technologies (NASDAQ:PTN) is slated to release their Q1 Fiscal Year 2027 operating results bright and early, before most of us have even sipped our coffee. The buzz around these numbers is as electric as any...

Continue Reading

Top 5 Most Recently Viewed Articles

Coherent Corp. Showcases Innovative Transceiver Technologies

Updated Category News Views 157

Coherent Corp. Introduces Next-Generation Transceiver Modules Coherent Corp. (NYSE: COHR) has recently captured attention by launching two innovative transceiver modules at the European Conference on Optical Communication (ECOC) 2024. These two models, the 1.6T-DR8 and 800G-DR4 transceivers, are specifically designed to significantly enhance data transmission speeds and...

Continue Reading
Provident Financial Holdings Set to Release Earnings Soon

Updated Category News Views 167

Provident Financial Holdings, Inc. Earnings Release Announcement Provident Financial Holdings, Inc. (Nasdaq: PROV) has recently shared significant news that will cap off their financial quarter. As a holding company for Provident Savings Bank, F.S.B., they are poised to announce their third-quarter earnings soon. This update is eagerly anticipated by both institutional...

Continue Reading
Rivalry Corp. Secures Funds to Propel Future Growth and Innovation

Updated Category News Views 177

Rivalry Corp. Closes Initial Tranche of Private Placement Rivalry Corp. (the “Company” or “Rivalry”) (TSXV: RVLY) (OTCQX: RVLCF) (FSE: 9VK), recognized as a leading sportsbook and iGaming operator dedicated to digital-first players, has reached a significant milestone by closing the first tranche of its non-brokered private placement. This announcement follows up...

Continue Reading
Understanding Insider Selling: Lessons From 3 Companies

Updated Category News Views 175

The Implications of Insider Selling Insider selling often triggers investor anxiety—but understanding the context is essential. Recently, sales at Dutch Bros, Monolithic Power Systems, and Palantir Technologies demonstrate that not all insider activity carries the same implications. In this article, we will break down the recent insider sales at these companies and...

Continue Reading
Quantum Corporation Faces Class Action Amid Financial Concerns

Updated Category News Views 173

Quantum Corporation Investors Urged to Act In light of recent challenges faced by Quantum Corporation, shareholders are advised to take note of significant developments that may impact their investments. As investors, it's crucial to stay informed, especially when issues arise that could potentially affect your financial standing. Financial Reporting Issues What Triggered...

Continue Reading